Every
second
counts!

Vanessa

Living with
Recurrent Pericarditis
8/3
Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity
6/8
Kiniksa Outlines Next Steps for the Development of Mavrilimumab
5/4
Kiniksa Announces Positive Final Data from Phase 1 Trial of KPL-404

It’s  . Today, right at this moment, we’re hard at work for patients like Vanessa who have a critical therapeutic need. We approach everything we do with a sense of urgency because, for them, we understand the clock is ticking—and that every second makes a difference.

 

Learn More

Patient Stories

Serving those who
don’t have time to wait.

Living with a debilitating disease brings questions that go far beyond the symptoms—there’s the fear and frustration of not knowing when, or if, there will ever be an answer. That’s why we’re relentless about making every moment matter at Kiniksa: because every second brings us closer to creating a better future for patients. Hear stories from the people who live with the uncertainty of these diseases every day.

hear
Jill's story

Living with
Recurrent Pericarditis

hear
Nadine’s story

Living with
Recurrent Pericarditis

hear
Vanessa's story

Living with
Recurrent Pericarditis

Connect with us on social media for up-to-date news and discoveries.